No Data
No Data
TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $8
TD Cowen Sticks to Their Buy Rating for GoodRx Holdings (GDRX)
We Think GoodRx Holdings (NASDAQ:GDRX) Can Manage Its Debt With Ease
Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating, Announces Target Price $5.5
Truist Cuts Price Target on GoodRx Holdings to $5.50 From $6.50, Keeps Hold Rating
Press Release: GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call